These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 38770370)

  • 1. Iron toxicity, ferroptosis and microbiota in Parkinson's disease: Implications for novel targets.
    Carvalho FV; Landis HE; Getachew B; Silva VDA; Ribeiro PR; Aschner M; Tizabi Y
    Adv Neurotoxicol; 2024; 11():105-132. PubMed ID: 38770370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential.
    Ding XS; Gao L; Han Z; Eleuteri S; Shi W; Shen Y; Song ZY; Su M; Yang Q; Qu Y; Simon DK; Wang XL; Wang B
    Ageing Res Rev; 2023 Nov; 91():102077. PubMed ID: 37742785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin-1 Rescues MPP
    Bai L; Yan F; Deng R; Gu R; Zhang X; Bai J
    Mol Neurobiol; 2021 Jul; 58(7):3187-3197. PubMed ID: 33634378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.
    Riederer P; Monoranu C; Strobel S; Iordache T; Sian-Hülsmann J
    J Neural Transm (Vienna); 2021 Oct; 128(10):1577-1598. PubMed ID: 34636961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin Protects against MPP
    Lin ZH; Liu Y; Xue NJ; Zheng R; Yan YQ; Wang ZX; Li YL; Ying CZ; Song Z; Tian J; Pu JL; Zhang BR
    Oxid Med Cell Longev; 2022; 2022():7769355. PubMed ID: 36105483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease.
    He N; Langley J; Huddleston DE; Chen S; Huang P; Ling H; Yan F; Hu X
    Neuroimage Clin; 2020; 28():102391. PubMed ID: 32889398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOX4 exacerbates Parkinson's disease pathology by promoting neuronal ferroptosis and neuroinflammation.
    Lin Z; Ying C; Si X; Xue N; Liu Y; Zheng R; Chen Y; Pu J; Zhang B
    Neural Regen Res; 2024 Jul; ():. PubMed ID: 38993139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson's Disease.
    Ko CJ; Gao SL; Lin TK; Chu PY; Lin HY
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-related factors in the substantia nigra are associated with Parkinson's disease.
    Liu L; Cui Y; Chang YZ; Yu P
    Sci Rep; 2023 Sep; 13(1):15365. PubMed ID: 37717088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACSL4 and the lipoxygenases 15/15B are pivotal for ferroptosis induced by iron and PUFA dyshomeostasis in dopaminergic neurons.
    Bouchaoui H; Mahoney-Sanchez L; Garçon G; Berdeaux O; Alleman LY; Devos D; Duce JA; Devedjian JC
    Free Radic Biol Med; 2023 Feb; 195():145-157. PubMed ID: 36581060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.
    Mahoney-Sánchez L; Bouchaoui H; Ayton S; Devos D; Duce JA; Devedjian JC
    Prog Neurobiol; 2021 Jan; 196():101890. PubMed ID: 32726602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ferroptosis underlies EGCG mediated protection against Parkinson's disease in a Drosophila model.
    Xia Y; Wang H; Xie Z; Liu ZH; Wang HL
    Free Radic Biol Med; 2024 Feb; 211():63-76. PubMed ID: 38092273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial iron dyshomeostasis and its potential as a therapeutic target for Parkinson's disease.
    Xiao Z; Wang X; Pan X; Xie J; Xu H
    Exp Neurol; 2024 Feb; 372():114614. PubMed ID: 38007207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis as a New Mechanism in Parkinson's Disease Therapy Using Traditional Chinese Medicine.
    Wu L; Liu M; Liang J; Li N; Yang D; Cai J; Zhang Y; He Y; Chen Z; Ma T
    Front Pharmacol; 2021; 12():659584. PubMed ID: 34163356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products.
    Yang K; Zeng L; Zeng J; Deng Y; Wang S; Xu H; He Q; Yuan M; Luo Y; Ge A; Ge J
    Ageing Res Rev; 2023 Nov; 91():102063. PubMed ID: 37673132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of p62-Keap1-Nrf2 Pathway Protects 6-Hydroxydopamine-Induced Ferroptosis in Dopaminergic Cells.
    Sun Y; He L; Wang T; Hua W; Qin H; Wang J; Wang L; Gu W; Li T; Li N; Liu X; Chen F; Tang L
    Mol Neurobiol; 2020 Nov; 57(11):4628-4641. PubMed ID: 32770451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insight into Parkinson's disease pathogenesis from reactive oxygen species-mediated extracellular Zn
    Atsushi T; Tamano H
    J Trace Elem Med Biol; 2020 May; 61():126545. PubMed ID: 32438294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC.
    Do Van B; Gouel F; Jonneaux A; Timmerman K; Gelé P; Pétrault M; Bastide M; Laloux C; Moreau C; Bordet R; Devos D; Devedjian JC
    Neurobiol Dis; 2016 Oct; 94():169-78. PubMed ID: 27189756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.
    Jansen van Rensburg Z; Abrahams S; Bardien S; Kenyon C
    Mol Neurobiol; 2021 Nov; 58(11):5920-5936. PubMed ID: 34426907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.